B
BridgeBio Pharma, Inc. (BBIO)
NMS – Real vaqt narxi. Valyuta: USD
70.24
+0.55 (0.79%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
70.91
+0.67 (0.95%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
70.24
+0.55 (0.79%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
70.91
+0.67 (0.95%)
Bozordan keyin: Jun 26, 2026, 7:59 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Umumiy qarz $3.4B naqd pul zahiralaridan ($880.4M) sezilarli darajada ko'p bo'lib, moliyaviy barqarorlik xavotirlarini keltirib chiqaradi
Jami joriy aktivlar $1.2B jami joriy majburiyatlardan $816.4M ko'p bo'lib, ajoyib likvidlikni ta'kidlaydi
Qarz/kapital nisbati (-1.5) tarmoq o'rtachasidan (0.3) sezilarli past bo'lib, ehtiyotkor moliyaviy boshqaruvni namoyish etadi
Foiz qoplash koeffitsiyenti (-2.0x) xavfli darajada past bo'lib, qarzni qaytarish xavflarini ko'rsatadi
Salbiy erkin pul oqimi -$197.3M kompaniyaning qayta investitsiya qilish yoki qarzni to'lash qobiliyatini cheklaydi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | 1.52 | 6.05 | 8.0 | |
| Tezkor likvidlik nisbati | 1.48 | 5.63 | 7.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | 2.47 | 1.04 | 1.0 | |
| Foiz to‘lov qoplami | -2.01 | -16.91 | 1.0 | |
| O‘rtacha ball | 3.6 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 78M | 9M | 222M | 502M | 580M |
| Yalpi foyda | 70M | 3M | 214M | 478M | 549M |
| Operatsion daromad | -468M | -599M | -577M | -502M | -504M |
| Sof foyda | -481M | -643M | -536M | -725M | -722M |
| EBITDA | -462M | -593M | -571M | -497M | -499M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 99.75 | 38.43 | 10 |
| Keyingi chorak | 111.56 | 50.24 | 10 |
| Joriy yil | 92.97 | 42.66 | 10 |
| Keyingi yil | 64.53 | 124.92 | 10 |
| O‘rtacha ball | 10 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 26.16 | 14.94 | 16 | -249.57 | 7.0 |
| Yil/Yil | 66.78 | 2.02 | 4.55 | 0.95 | 4.8 |
| 3 yil o‘rtacha | 774.51 | -17.41 | -8.43 | -2.83 | 3.3 |
| 5 yil o‘rtacha | 616.01 | -12.62 | -2.29 | -3.46 | 3.3 |
| O‘rtacha ball | 4.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Zaif | 2.0 |
| Nomoddiy aktivlar | O'rtacha | 5.0 |
| O'zgartirish xarajatlari | Zaif | 2.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Zaif | 3.0 |
| O‘rtacha ball | 2.6 | |